Download PDF
Exp Clin Endocrinol Diabetes 2024; 132(04): 171-180
DOI: 10.1055/a-2166-6566
German Diabetes Associaton: Clinical Practice Guidelines

Fundamentals of Diabetes Management

Bernhard Kulzer
1   Diabetes Centre Mergentheim, Research Institute of the Diabetes Academy Bad Mergentheim, University of Bamberg, Germany
,
Jens Aberle
2   Section Endocrinology and Diabetology, University Obesity Centre Hamburg, University Hospital Hamburg-Eppendorf, Hamburg, Germany
,
Thomas Haak
3   Diabetes Center Mergentheim, Bad Mergentheim, Germany
,
Matthias Kaltheuner
4   dialev, Diabetes Centre for Internal and General Medicine, Leverkusen, Germany
,
Jens Kröger
5   diabetesDE-German Diabetes Aid, Berlin, Germany
,
Rüdiger Landgraf
6   German Diabetes Foundation, Düsseldorf, Germany
,
Monika Kellerer
7   Department of Internal Medicine, Marienhospital, Stuttgart, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

NOTICE OF UPDATE

The DDG clinical practice guidelines are updated regularly during the second half of the calendar year. Please ensure that you read and cite the respective current version.



Publication History

Article published online:
20 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Haak T, Gölz S, Fritsche A. et al. Therapie des Typ-1-Diabetes. Diabetologe 2019; 15: 135-145
    CrossrefPubMedGoogle Scholar
  • 2 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Typ-2-Diabetes – Teilpublikation der Langfassung 2021. 2. Auflage. Version 1. Online (Retrieved from: 17.08.2021): www.leitlinien.de/diabetes
    PubMed
  • 3 Gemeinsamer Bundesausschuss: Richtlinie des Gemeinsamen Bundesausschusses zur Zusammenführung der Anforderungen an strukturierte Behandlungsprogramme nach § 137f Absatz 2 SGB V (DMP-Anforderungen-Richtlinie/DMP-A-RL). Online (Retrieved from: 17.08.2021): https://www.g-ba.de/downloads/62-492-2111/DMP-ARL_2020-03-27_iK-2020-04-08.pdf
    PubMed
  • 4 Nicolucci A, Kovacs Burns K, Holt RIG. et al. Correlates of psychological outcomes in people with diabetes: results from the second Diabetes Attitudes, Wishes and Needs (DAWN 2™) study. Diabet Med 2016; 33: 1194-1203
    CrossrefPubMedGoogle Scholar
  • 5 Kulzer B, Lüthgens B, Landgraf R. et al. Diabetesbezogene Belastungen, Wohlbefinden und Einstellung von Menschen mit Diabetes. Diabetologe 2015; 11: 211-218
    CrossrefPubMedGoogle Scholar
  • 6 Kulzer B, Lüthgens B, Landgraf R. et al. Wie belastend erleben Angehörige den Diabetes?. Diabetologe 2017; 13: 570-580
    CrossrefPubMedGoogle Scholar
  • 7 Jacobs E, Hoyer A, Brinks R. et al. Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany. Diabetes Care 2017; 40: 1703-1709
    CrossrefPubMedGoogle Scholar
  • 8 Elwyn G, Vermunt NP. Goal-Based Shared Decision-Making: Developing an Integrated Model. J Pat Exper 2020; 7: 688-696
    PubMedGoogle Scholar
  • 9 Bierwirth R, Paust R. Hrsg. Compliance und Empowerment in der Diabetologie. Bremen: UNI-MED Science; 2004
    Google Scholar
  • 10 Davies MJ, D’Alessio DA, Fradkin J. et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41: 2669-2701
    Google Scholar
  • 11 Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006; 60: 301-312
    CrossrefPubMedGoogle Scholar
  • 12 Schunk M, Stark R, Reitmeir P. et al. Towards patient-oriented diabetes care: results from two KORA surveys in southern Germany. J Diabetes Res 2015; 2015: 368570
    CrossrefPubMedGoogle Scholar
  • 13 Inzucchi SE, Bergenstal RM, Buse JB. et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596
    CrossrefPubMedGoogle Scholar
  • 14 Dankwa-Mullan I, Rivo M, Sepulveda M. et al. Transforming diabetes care through artificial intelligence: the future is here. Popul Health Manag 2019; 22: 229-242
    CrossrefPubMedGoogle Scholar
  • 15 Kulzer B. Wie profitieren Menschen mit Diabetes von. Big data, künstlicher Intelligenz? Diabetologie 2021; 17: 799-809
    PubMedGoogle Scholar
  • 16 Stellungnahme der Bundesärztekammer Präzisionsmedizin: Bewertung unter medizinisch-wissenschaftlichen und ökonomischen Aspekten. Dtsch Arztebl 2020; 117: A-1184/B-1000
    PubMed
  • 17 Chung WK, Erion K, Florez JC. et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020; 63: 1671-1693
    CrossrefPubMedGoogle Scholar
  • 18 Ceriello A, Barkai L, Christiansen JS. et al. Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract 2012; 98: 5-10
    CrossrefPubMedGoogle Scholar
  • 19 Kulzer B, Daenschel W, Daenschel I. et al. Integrated personalized diabetes management improves glycemic control in patients with insulintreated type 2 diabetes: results of the PDM-ProValue study program. Diabetes Res Clin Pract 2018; 144: 200-212
    CrossrefPubMedGoogle Scholar
  • 20 Lange K, Ziegler R, Neu A. et al. Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program. Curr Med Res Opin 2015; 31: 477-485
    CrossrefPubMedGoogle Scholar
  • 21 Petrak F, Meier J, Albus C. Motivation und Diabetes – Zeit für einen Paradigmenwechsel? – Ein Positionspapier. Diabetologie 2019; 14: 193-203
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 2016; 10: 1299-1307
    CrossrefPubMedGoogle Scholar
  • 23 Khunti K, Seidu S, Kunutsor S. et al. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care 2017; 40: 1588-1596
    CrossrefPubMedGoogle Scholar
  • 24 Khunti K, Gomes MD, Pocock S. et al. Therapeutic inertia in the treatment of hyperglycemia in patients with type 2 diabetes: A systematic review. Primary Care Diabetes 2017; 11: 3-12
    PubMedGoogle Scholar
  • 25 Edelman S, Polonsky W. Type 2 Diabetes in the real world. Diabetes Care 2017; 40: 1425-1432
    CrossrefPubMedGoogle Scholar
  • 26 O’Connor P, Sperl-Hillen JM, Johnson PE. et al. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, et al, Hrsg. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005: 293-304
    Google Scholar
  • 27 Müller-Wieland D, Ickrath M. Die elektronische Diabetesakte eDA der DDG (Deutsche Diabetes Gesellschaft). Diabetologe 2021; 3: 1-5
    PubMedGoogle Scholar